MMPs are inhibited either directly or by culturing SMCs on floating collagen gels, endogenous TN levels are markedly reduced, and SMC apoptosis is evident. Recent studies carried out in organ culture confirmed that SMCs in the hypertrophied PA responded similarly in attached and floating collagen gels and established that changes in elastase activity correlate with MMP activity (22) .
We now show that direct inhibition of MMPs, including gelatinolytic activity attributable to MMP-2, or of serine elastases, leads to reduced TN, induction of apoptosis, loss of ECM, and regression of PA hypertrophy. Transfection of a TN antisense/ribozyme expression vector reduced TN mRNA and protein and resulted in considerable SMC apoptosis, although proliferation also occurred. This procedure arrested progressive hypertrophy, but failed to induce regression. Immunohistochemistry revealed an increase in osteopontin (OPN), an alternative α v β 3 ligand, possibly in response to cues provided by a proteolytic environment. We confirm that OPN functions as a survival factor rescuing SMCs from MMP inhibitor-induced apoptosis and that α v β 3 blockade can promote SMC apoptosis.
Methods
Preparation of explants. PAs were harvested from adult male Sprague-Dawley rats (300 g) (Charles River Laboratories, St. Laurent, Quebec, Canada) 21 days after a subcutaneous injection of 60 mg/kg of the alkaloid toxin Mct (Sigma Chemical Co., St. Louis, Missouri, USA) or an equal volume of saline in accordance with protocols approved by the Animal Care Committee of The Hospital for Sick Children. The rats were sacrificed, and PAs were excised and cultured in attached type I collagen gels as described previously (22) .
Experimental designs.
In the first set of experiments, organ cultures were supplemented with 1 of the following 3 proteinase inhibitors or with their administration vehicles. Administered were 6 mg/mL of the general serine elastase inhibitor alpha 1 -proteinase inhibitor (α 1 -PI; endotoxin-free Prolastin, a kind gift from M.A. Lark, Cutter Biologicals, Etobicoke, Ontario, Canada) in PBS, 8 µM of the synthetic MMP inhibitor GM-6001 (a kind gift from S. Sweidler, Glycomed, Alameda, California, USA) dissolved in 0.4% DMSO (Calbiochem-Novabiochem Corp., La Jolla, California, USA) or 0.8 µM of the selective neutrophil elastase inhibitor 1K (ZD0892; a kind gift from C. Veale, Zeneca Pharmaceuticals, Wilmington, Delaware, USA), delivered in 5% polyethylene glycol (PEG; Sigma Chemical Co.). Inhibitors were chosen to target MMPs or the heightened elastase activity demonstrated in Mctinduced vascular disease (8, 18, 21, 22) . Doses were based upon our previous studies (11, 18, 23) .
As mentioned previously, α 1 -PI is a broad-spectrum serine proteinase inhibitor (24) . GM-6001, an N-[2(R)-2-(hydroxamidocarbonylmethyl)-4-methylpentanoyl]-Ltryptophan methylamide, is a noncytotoxic, synthetic inhibitor that functionally and specifically inhibits MMP activity, by complexing with the zinc atom found in the active site of MMPs, and prevents substrate interaction, as described (18) . 1K (ZD0892) is a peptidyl trifluoromethyl ketone with an N-terminal 4-(CH 3 O)C 6 H 4 CO group, making it an orally bioavailable serine elastase inhibitor (25) . It is highly selective for neutrophil elastase (K i = 6.7 nM), but also inhibits pancreatic elastase (K i = 200 nM) and endogenous vascular elastase (unpublished data), but not other serine proteinases, or cysteine, or metalloproteinases. It is preferable to elafin, which is relatively unstable and must be given by continuous administration (26) . The EcoRI and SpeI restriction sites are underlined. Hairpin loops at the 5′ and 3′ ends are shown, and the 32-bp antisense RNA described in the text is constructed to incorporate a hammerhead ribozyme such that it folds and hybridizes to the target TN mRNA at the location of the GUC consensus cleavage site (arrow, site of cleavage).
Preparation of sense and antisense vectors for transfection. A U1Bam pZeo mut EcoRI/SpeI expression vector backbone was a gift from H.C. Dietz and R.A. Montgomery (Johns Hopkins University School of Medicine, Baltimore, Maryland, USA) (27) . Ligated into this plasmid, downstream from a constitutively active U1 promoter and between 2 snRNA hairpin loops, was a 32-bp antisense construct directed toward the 6th FN type III constant domain of rat TN (coding sequence 5′-GAAAATGCAGC-CACA .... TCAGCTGGAGGGCACCG-3′) and interrupted in its middle by a 22-bp sequence (relative to TN coding sequence 5′-CAAAGCAGGAGTGCCTGAGTAG-3′) encoding a hammerhead ribozyme. Antisense target sequence selection involved maintenance of hairpin loop 2°structures and targeting of the ribozyme to mRNA containing a GUC ribozyme consensus cleavage site (Figure 1 ). Folding of the resultant cRNA activates the encoded ribozyme such that binding of the construct to the target TN mRNA results in cleavage of the TN mRNA at the consensus cleavage site, destabilizing it, and leading to its degradation and loss by endogenous exonuclease activity. The cRNA produced by the vector is particularly stable because of the presence of the 5′ and 3′ hairpin loops that confer resistance to exonuclease activity as a result of their high G + C content and facilitate nuclear trafficking of the construct because of lack of polyadenylation and the presence of a 5′-trimethyl guanosine cap. Sense and antisense oligonucleotides containing alternative 4-bp EcoRI and SpeI overhangs (antisense: 5′-CTAG GAA AAT   GCA GCC ACA GTT TCG TCC TCA CGG ACT CAT CAG AGC   TGG AGG GCA CCG; sense: 5′-AATT CGG TGC CCT CCA   GCT CTG ATG AGT CCG TGA GGA CGA AAC TGT GGC TGC   ATT TTC) were denatured, annealed, and ligated into the EcoRI and SpeI (Pharmacia Biotech AB, Uppsala, Sweden) linearized expression vector using T4 DNA ligase (GIBCO-BRL, Gaithersburg, Maryland, USA).
Before transfection, plasmid DNA was linearized with ApaI (Pharmacia) and bound to the non-histone-associated nuclear proteins, high mobility group-1 and -2 (HMG-1 and -2) (Wako Pure Chemical Industries, Osaka, Japan), to facilitate nuclear targeting of the plasmid DNA (28) . The plasmid/HMG complex was enclosed in liposomes and bound with ultraviolet-inactivated hemagglutinating virus of Japan (HVJ; a kind gift from Y. Kaneda and N. Nakamura, Osaka University, Japan).
PAs were excised and both infused and incubated for 10 minutes in 250 µL of buffered saline containing 2 nM of CaCl 2 and 7,500 hemagglutinating units of HVJ bound to liposomes containing 50 µg of TN sense or antisense plasmid DNA or the constitutively active reporter expression plasmid pECE-CAT encoding fulllength chloramphenicol acetyltransferase (CAT).
Blocking α v β 3 integrin. Hypertrophied PAs were cultured in media supplemented with either 15 µg/mL of an anti-α v β 3 functional blocking antibody, LM609 (Chemicon, Temecula, California, USA), or 15 µg/mL of control IgG (PharMingen, San Diego, California, USA), as described previously for cell culture (18) .
Cell culture. Vascular SMCs were isolated from the excised PAs of Sprague-Dawley rats, and confluent cultures were collected by trypsinization and seeded on prepared collagen gels as described previously (18) . Briefly, SMCs were cultured for 48 hours in medium 199 (Sigma Chemical Co.) with 0.1% BSA and 50 ng/mL epidermal growth factor (GIBCO BRL) and on gels containing either collagen alone or supplemented with 100 nM recombinant wild-type OPN expressed in E. coli as a glutathione Stransferase fusion protein (a kind gift from C.M. Giachelli, University of Washington, Seattle, Washington, USA) (29) . Cell number was determined following collagenase digestion and counts were made using an improved Neubauer hemocytometer (American Optical, Buffalo, New York, USA). Survival was quantified as the percent of SMCs present at 48 hours relative to the number of seeded cells (cells plated -cells in medium).
Figure 2
Elastase and MMP activity. Elastase assays were used to detect net elastolytic activity in conditioned medium harvested from 8-day-old PA cultures in the presence or absence of either the serine elastase inhibitors, α 1 -PI and 1K, active against endogenous vascular elastases, or the MMP inhibitor, GM-6001 (a). Suppression of elastase activity was induced by all 3 inhibitors. Gelatin zymography, performed on tissue extracts of PAs grown for 8 days in media supplemented with either α 1 -PI or GM-6001, or with the administration vehicle controls for each inhibitor, allowed us to see MMP activity (b). The most predominant bands ran as a doublet at a molecular weight of approximately 56 and 52 kD, as shown in the zymogram, representative of 3 such experiments and summarized graphically. Bars: mean + SEM (n = 3); *P < 0.05 compared with administration vehicle controls.
Elastase assay, and MMP activity and expression. The ability of conditioned media to degrade 200 µg of [ 3 H]-elastin was determined as described previously (22) . To control for nonenzymatic degradation, radiolabeled elastin was incubated with medium cultured in the absence of tissue. Activity was related to a standard curve generated with human leukocyte elastase (0.075-5.0 ng) (Elastin Products Co., Pacific, Missouri, USA). MMP zymography was performed after homogenization of PA tissue as described previously (22) and normalized by Bradford assay to total protein (Bio-Rad Laboratories, Hercules, California, USA). MMP Western immunoblotting used an anti-MMP-2 rabbit polyclonal antisera (a kind gift from M. Silverman and M. Ailenburg, University of Toronto, Toronto, Ontario, Canada) as described previously (22) .
Northern blotting for TN. Northern blot analysis was performed on 8 µg of total RNA extracted from 3 pooled PAs and hybridized to a 250-bp cDNA probe derived from the 7th FN type III constant domain of rat TN (22) . TN mRNA was corrected for loading conditions by direct comparison with 28S rRNA, detected after ethidium bromide staining, and GAPDH, following hybridization with a rat-specific probe.
Immunohistochemistry and detection of apoptosis. Immunohistochemistry, using techniques described previously (22) , identified TN with an anti-rat formaldehyde-fixed TN polyclonal antibody (1:100; a generous gift from H. Erickson, Duke University Medical Center, Durham, North Carolina, USA). For detection of proliferating cell nuclear antigen (PCNA), an anti-PCNA mAb (1:100) (DAKO Inc., Carpinteria, California, USA) was used. Immunohistochemistry for OPN was performed with a mAb raised against rat bone OPN, clone MPIIIB10 1 (11 ng/mL; Department of Biological Sciences, University of Iowa, Iowa City, Iowa, USA). FN was detected using an anti-FN mAb (1:100; Chemicon). For CAT immunostaining, an anti-CAT polyclonal antibody (1:50; 5 Prime -3 Prime Inc., Boulder, Colorado, USA) was used. Estimates of total elastin and collagen were detected using the Movat pentachrome stain. To quantify apoptosis, TUNEL assays were performed with the ApopTag in situ detection system (Oncor Inc., Gaithersburg, Maryland, USA). Nuclear morphology was examined by labeling with propidium iodide (2 µg/mL). DNA laddering was performed as described previously (18) . In the cell culture studies, apoptosis was confirmed as the mechanism for reduced cell number using the DePsipher detection system (R&D Systems Inc., Minneapolis, Minnesota, USA), which indicates loss of mitochondrial membrane potential. This assay correlates well with TUNEL and can be expediently applied to cells in culture but not readily to whole-tissue samples.
The relative abundance of the ECM components examined were graded quantitatively in 5 random fields (×400) per sample, using the Image-Pro Plus program for Macintosh (Media Cybernetics LP, Silver Spring, Maryland, USA). The program performs planimetry and densitometry on positive staining above a uniform "background" cutoff. Subsequent multiplication of both the total area positively stained and the average density of staining provides a relative densitometric unit of ECM protein content that was then averaged, and tissue means were calculated. The relative number of proliferating and apoptotic cells was quantitatively assessed in 10 randomly selected fields (×400) as a percent of total propidium iodide-stained cells.
Lactate dehydrogenase assay. Necrosis was assessed by a lactate dehydrogenase (LDH) release assay kit (Sigma Chemical Co.). Controls included tissue-free medium cultured with and without FBS, as well as supernatants from PA SMCs following freeze-thaw cycles.
Morphometric analysis of Movat pentachrome-stained sections. Twenty-five measurements of medial thickness, from internal to external elastic lamina, were recorded over the length of each vessel, and the means were calculated.
Statistical analysis. Values from multiple experiments are expressed as mean ± SE, and statistical significance was determined using 1-way ANOVA followed by Fisher's least significant difference test of multiple comparisons to establish differences between individual groups. The number of samples in each group is indicated in the figure legends.
Results
Serine elastase and MMP inhibition and TN deposition. TN is upregulated in SMCs cultured on proteolyzed collagen and suppressed following inhibition of MMP activity (18) . Increased activity of a 20-kD serine elastase (9) and MMP-2 (22) have been observed in PAs following Mct injection. We therefore addressed the effects of inhibitors of serine elastases, including endogenous vascular elastase, or of MMPs on TN expression in rat PAs 21 days after Mct injection and after 8 days in organ culture. Degradation of [ 3 H]-elastin in conditioned medium from PA organ cultures was reduced in experiments with α 1 -PI, 1K, and the MMP inhibitor GM-6001 compared with their vehicle controls (P < 0.05) (Figure 2a ). Whereas the exact nature of the enzyme in the PA responsible for the elastase activity has not been identified, it is likely the endogenous serine elastase described previously in the hypertrophied PA after Mct injection, which would be inhibited by both α 1 -PI and the more selective agent, 1K. However, GM-6001 also inhibits the elastolytic activity, suggesting that there is either an equally important MMP elastolytic component or that MMPs regulate serine elastases, possibly by inactivating inhibitors (30) . The elastolytic activity measured is relatively small but it may reflect only the fact that most of the secreted elastases would be bound by inhibitors such as α 2 -macroglobulin or α 1 -PI or tissue inhibitors of MMPs (TIMPs), which are present in the serum component of the conditioned media.
Gelatin zymography for MMP activity using tissue extracts from the same PA organ cultures detected multiple gelatinolytic bands, the most prominent of which was a doublet at approximately 56 and 50 kD (displayed in Figure 2b ). This gelatinolytic doublet corresponded to MMP activity because it was suppressed by the zinc/calcium chelator EDTA and was identified by Western immunoblotting of a similar native gel to be the latent and active form of MMP-2 (data not shown). An approximately 3-fold suppression in MMP-2 activity was observed with serine elastase or MMP inhibitors compared with vehicle-treated controls (P < 0.05; Figure 2b ). The suppression of latent MMP-2 could result from proteinase inhibition, because there would be a reduction in the ECM degradation products that normally stimulate transcription of the enzyme (31, 32) . Whereas we focused on MMP-2 based on previous studies (18, 22) , additional, less prominent bands were also inhibited with GM-6001 and/or EDTA, suggesting the possible involvement of other MMPs. In addition, the inhibitory profile of GM-6001 may include members of the ADAM family of proteinases (33) . Taken together, our organ culture data suggest suppression of elastases and MMPs in an interdependent manner.
Deposition and localization of TN within PAs was documented by immunohistochemistry. TN accumulation was increased in association with Mct-induced PA hypertrophy (20) and deposited throughout the vessel wall (Figure 3a , relative to saline control in Figure 3b ). This deposition pattern was maintained or enhanced over 8 days in organ culture in the presence of the administration vehicles for the inhibitors: PBS (Figure 3c (Figure 4h ) all induced widespread TUNEL positivity, primarily within the vessel media, but also in the adventitia and endothelium. The percent of these cells was quantified with α 1 -PI (15%), GM-6001 or 1K (30% for both), and vehicle controls (∼5-7%) (P < 0.05; Figure  5a ). The appearance of TUNEL-positive cells correlated with nuclear fragmentation and condensation. To determine whether the tissues were necrotic because of the cytotoxicity of the inhibitors, LDH assays were performed, but no enhanced activity was apparent compared with controls (data not shown).
To address the specificity of proteinase inhibition on the induction of apoptosis in Mct-treated hypertrophied PAs, we examined vessels from saline-injected rats in organ culture with media supplemented with proteinase inhibitors or their administration vehicles. TUNEL assays indicated that vascular cells from these vessels did not undergo apoptosis (Figure 5b) .
Proteinase inhibition of PA organ cultures and SMC proliferation. Studies with PA SMC cultures on TN-supplemented collagen gels indicate that TN's role in disease may occur through an induction of growth-factor responsiveness in these cells (20) . To determine whether modulation of TN within a 3-dimensional native vessel configuration will affect the proliferative potential of vascular cells we performed PCNA immunohistochemistry on cultured tissue (depicted in Figure 5c , photomicrographs not shown; P < 0.05 for each comparison). Low levels of proliferating cells, judged by PCNA positivity (∼3%), were present in PAs from rats 21 days after treatment with Mct (in contrast to saline controls where values were < 1%). The further increase in PCNA positivity in organ culture was documented with vehicle-treated samples, either PBS (α 1 -PI control) or PEG (1K control; ∼12% for both), but not with DMSO (GM-6001 control). A reduction of PCNA positivity occurred with all 3 inhibitors: α 1 -PI, GM-6001, and 1K (P < 0.05). Proteinase inhibitors do not influence proliferation in cultured control vessels from saline-injected rats as judged by PCNA immunostaining, which is less than 1%.
Proteinase inhibitors and regression of vessel wall hypertrophy. To determine whether regression of medial hypertrophy occurs as a result of proteinase inhibition and apoptosis, we measured PA wall thickness in Movat pen-
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The tachrome-stained tissue sections (Figure 6 , a-h, and quantified in Figure 6i ). Consistent with previous reports (8) , Mct induced an increase in vessel wall thickness ( Figure 6 , a and i) compared with PAs derived from saline-injected rats ( Figure 6 , b and i). PAs cultured with administration vehicle controls continued to thicken ( Figure 6 , c, e, and g show PBS, DMSO, and PEG, respectively). In contrast, proteinase inhibitors showed regression of wall thickness to saline control levels with α 1 -PI (Figure 6d ) and to below those levels with GM-6001 ( Figure 6f ) and 1K (Figure 6h ) (displayed graphically in Figure 6i ; P < 0.05 for comparisons). The greatest reduction in wall thickness was observed using either the specific serine elastase or MMP inhibitors, 1K (64% reduction) and GM-6001 (45% reduction). TN antisense and MMP activity. Because reduced TN was associated with regression of vessel wall thickness following MMP or elastase inhibition, we next addressed whether selective suppression of TN would reproduce these effects. The TN antisense expression vector was administered using the HVJ-liposome method, which facilitates a high rate of delivery to blood vessels in vivo (28) . To evaluate the relative efficiency of this methodology in our model, transfections using a CAT construct were performed. Relative to mock-transfected controls (Figure 7a ), abundant CAT immunostaining was observed throughout the vessel media, adventitia, and along the endothelium (Figure 7b) . TN, detected by immunohistochemistry, was present in PAs of Mct-treated rats and increased over the 8 days in organ culture with no significant difference between mock-and sense-transfected vessels (P < 0.05; Figure 7c , densitometric quantification). However, in PAs transfected with antisense cRNA, a significant reduction in TN deposition, to below preculture levels, was observed (56% relative to sense-transfected vessels; P < 0.05). The reduction in protein was attributed to antisense/ribozyme-mediated loss (58%) of both the 7.3-and 6.4-kb TN mRNA transcripts, compared with sensetransfected vessels, and observed as early as 18 hours after transfection (P < 0.05; Figure 7d ). TN modulation by antisense was confirmed to be downstream of MMP activity because no difference in MMP-2 activity was detected (data not shown).
Antisense suppression of TN and induction of apoptosis. We next determined whether decreasing TN by antisense impairs cell survival and leads to apoptosis (Figure 8a) . In freshly isolated Mct-treated PAs, apoptosis was not observed. In mock-and sense-transfected vessels, 7-10% of cells were TUNEL positive after 8 days in organ culture, but in antisense-transfected vessels, the level of apoptosis was increased to approximately 40% of cells (P < 0.05). We confirmed that the TUNEL-positive cells were, in fact, associated with nuclear condensation and fragmentation and DNA laddering. PAs transfected with the sense construct displayed mostly normal nuclear staining and morphology assessed by propidium iodide labeling, whereas in antisense-transfected vessels approximately 12% of nuclei exhibited
Figure 6
Proteinase inhibitors and regression of vascular hypertrophy. Representative Movat pentachrome-stained sections are shown in a-h. An increase in vessel thickness following Mct-injection (a), relative to that following saline-injection (b), but before placement into organ culture is shown. Vessels cultured in the absence of proteinase inhibition showed a further increase in wall thickness over 8 days: (c) PBS for α 1 -PI; (e) DMSO for GM-6001; and (g) PEG for 1K. Wall thickness was reduced to or below values of saline vessels when PAs were cultured with (d) α 1 -PI, (f) GM-6001, or (h) 1K. Whereas the size of control vehicle-treated vessels is such that they cannot be shown in entirety, differences in wall thickness are quantitatively displayed (i). Bar: 25 µm; graph bars: mean + SEM (n = 6); *P < 0.05 compared with vehicle control; P < 0.05 compared with preculture Mct.
bright focal centers, indicative of DNA chromatin condensation (P < 0.05; Figure 8b ). Nuclear fragmentation was also observed in approximately 7-8% of cells in TN antisense-transfected vessels, whereas very few such cells (< 2%) were noted in sense control PAs (P < 0.05; Figure 8b ). DNA laddering, a hallmark of apoptosis resulting from degradation of nucleosomal DNA, was observed in sense organ cultures, but antisense transfection resulted in a 3-fold increase in intensity of these bands (P < 0.05; Figure 8c ).
TN antisense, vascular cell proliferation, and vascular thickening. To establish whether suppression of SMC proliferation following proteinase inhibition was also observed with TN antisense, PCNA immunohistochemistry was performed (Figure 9a) . A significant induction in PCNA positivity was detected above preculture levels in both the mock and sense controls, as well as with antisense transfection (P < 0.05 for each comparison). Thus, loss of TN by antisense failed to suppress proliferation in PA organ culture. Because suppressing TN by antisense induced apoptosis but did not arrest proliferation, the net effect on wall thickness was assessed morphometrically (quantified in Figure  9b ). Whereas a significant increase in wall thickness, above day 21 controls, was observed in mock-and sense-transfected vessels (P < 0.05), in antisense-transfected arteries wall thickness was similar to that observed in freshly isolated, Mct-treated PAs (P < 0.05). TN amplifies the response to growth factors by ligating β 3 integrin receptors, altering the cytoskeleton, and causing clustering and enhancing activation of growth factor receptors. OPN, another ECM molecule that contains an arginine-glycine-aspartic acid (RGD) site required to ligate β 3 integrins, mediates vascular endothelial cell survival (29) and is produced by SMCs during disease (34) . We therefore investigated, using immunostaining, whether OPN was present or upregulated. The diffuse, sometimes focal, pattern of OPN deposition in sense-transfected PAs was reduced relative to preculture levels after 8 days in organ culture (Figure 11, a and e) . With suppression of TN by antisense, however, OPN immunoreactivity was markedly increased and localized primarily to intense, dense foci (P < 0.05; Figure  11 , c and e). In serial sections there appeared to be an enhanced codistribution of PCNA-positive cells with intense OPN staining in antisense vessels ( Figure  11 ). The suppression of TN and concomitant upregulation of OPN in antisense PAs were selective effects, because other ECM molecules such as FN, elastin, and collagen were not altered in proportion to wall thickness (Figure 11e ).
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The To further explore the role of OPN as a SMC survival factor and to ensure uniform delivery of exogenous OPN, we used a PA SMC culture model characterized previously (18) . We cultured rat PA SMCs with the proteinase inhibitor GM-6001, which suppresses TN (18) , and showed induction of apoptosis (∼50% cell loss over 48 hours), detected as DePsipher positivity as described in Methods. This rapid assay for cultured cells avoids the fixation process necessary for tissue pieces. Addition of exogenous OPN (Figure 13a ), prevented the loss in cell number through the suppression of apoptosis (reduced by approximately 5-fold; P < 0.05).
Blockade of α v β 3 integrin, vascular cell apoptosis, and vascular regression. Because TN or OPN-dependent survival has been shown to involve the ligation of α v β 3 integrins (18, 29), we determined whether the absence of matrix interaction with this integrin could account for apoptosis and vascular regression. Hypertrophied PA organ cultures were therefore treated with the functional blocking antibody, LM609, as described in Methods. An apoptotic response was observed (∼5.8-fold induction), similar to that detected with proteinase inhibitors (Figure 13e and quantified in Figure 13f ), whereas untreated vessels ( Figure 13c , after culture; Figure 13b , before culture) and IgG (Figure 13d ) controls maintained low levels of TUNEL positivity (P < 0.05). This was again associated with regression of vascular hypertrophy (P < 0.05; Figure 13g ).
Discussion
PA organ culture was used to show that inhibition of elastases and MMPs suppresses TN, and this not only arrests progression but leads to regression of the thickened vessel wall in association with apoptosis and reduction in ECM components. An antisense technique effectively suppressed TN and caused a similar degree of SMC apoptosis, but proliferation of a group of TN-negative SMCs continued unaffected in association with enhanced deposition of an alternative ECM protein survival factor, OPN. regression, similar to proteinase inhibition. Taken together, this suggests that a PA SMC subpopulation is highly adaptive to survival ligand usage stimulated by the growth-promoting proteolytic environment. Thus a strategy aimed at either inhibiting the general sequelae of proteolytic events, e.g., stimulation of ECM deposition and release of growth factors, or common survival signaling pathways may be more effective in inducing regression of disease than the more selective approach of targeting a specific ECM molecule. In this study we adapted an organ culture system used previously to show the development of a neointima in porcine aorta in association with SMC proliferation (35) . Those studies showed that the mechanism of SMC proliferation is likely related to serine elastase activity (11) . Serine elastases are known to stimulate SMC proliferation by releasing growth factors such as FGF-2 from ECM proteoglycans (10) . Through the proteolysis of collagen, elastases can expose RGD binding sites (36) , which induce β 3 integrin-dependent upregulation of the matrix glycoprotein TN (21) , amplifying the SMC proliferative response by facilitating phosphorylation of growth factor receptors upon their ligation (18) . In previous cell culture studies, stress unloading inhibited MMPs, suppressed TN, and induced SMC apoptosis. Recently, we showed that the response of SMCs in hypertrophied but not normal arteries to stress unloading in organ culture was similar (22) . We also documented reduced elastase activity and showed that these effects translated into regression of the thickened vessel wall. It would be interesting to use available transgenic knockout mice to further explore the selective roles of MMPs, TN, and OPN. The effects observed are, however, limited to hypertrophied vessels, and Mct does not induce pulmonary vascular disease in mice.
Increased activity of both serine elastases and MMPs is associated with vascular remodeling (6, 7, 16, 17) , and using either serine elastase inhibitors or MMP inhibitors over the 8 days in organ culture resulted in a similar reduction in elastase and MMP activity. It would therefore appear that progressive medial hypertrophy depends on an interaction between MMPs and serine elastases. Serine elastases could allow for activation of MMPs directly, or by inactivation of inhibitors, or vice versa. For example, if the endogenous serine elastase is similar to other elastases, such as neutrophil or pancreatic elastase, it could activate latent MMPs (12) and degrade TIMPs, and, by destabilizing TIMP-MMP complexes, facilitate release of the active enzyme (13) . Elastases also release elastin or FN-derived peptides as well as ECM-incorporated FGF-2 (10), all of which can increase MMP expression and activity (14, 15, 32) . Whereas elastases do not require proteolysis for activation, MMP-mediated 30 The (30), may enhance vascular elastolytic activity. In addition, MMPs activated in association with endothelial injury may degrade matrix components leading to the loss of the basement membrane barrier (37) and allow serum factors to stimulate SMC elastase activity (6, 7) . Alternatively, both serine elastase and MMP activities are independently associated with progressive disease, and inhibition of either serine elastase or MMP activity is sufficient to induce regression. Our previous studies examining Mct-induced PA hypertrophy attributed the elevated elastase activity to a 20-kD serine elastase (9) . Matrix metalloelastases, however, were not evident, and non-elastolytic activity of MMPs was not assessed (8) .
Evidence for the importance of a TN-SMC interaction in vascular biology comes from characterization of TN's tight developmental regulation and pathological reexpression (19, 20, 38) . Cell culture studies have identified a number of factors that influence TN expression (39, 40) , and these include MMPs that are also coinduced during vascular disease (16, 17, 19, 20) . The mechanism involves proteolysis of native type I collagen and ligation of newly exposed RGD sites by β 3 integrin receptors on SMCs (18) . The subsequent intracellular signaling leads to transactivation of the TN promoter (21) . Furthermore, elastases can release stored matrix-bound growth factors such as FGF-2 (10), which can also stimulate production of TN (39) . How inhibition of elastases, also shown recently in the intact animal (unpublished data), or MMPs (18) reduce TN expression is not known, but this may be related to suppression of the β 3 integrin-directed morphological changes and downstream signaling events described previously (21) .
The mechanism whereby suppression of TN resulting either from reduced elastase or MMP activity or TN mRNA antisense leads to SMC apoptosis is not known. Because α v β 3 ligation to TN results in a reorganization of the SMC filamentous actin cytoskeleton, focal adhesion morphology, and ultimately cell-shape (18) regulating cell behavior (41, 42) , loss of this ligation to TN may initiate the apoptotic cascade. Correspondingly, apoptosing cells can be rescued by addition of exogenous TN (18) . Our studies documenting induction of SMC apoptosis with an α v β 3 functional blocking antibodywould support suppression of α v β 3 ligation as the mechanism.
We further suggest that if SMCs respond similarly to endothelial cells, α v β 3 ligation may involve nuclear factor-κB-related (NF-κB-related) signaling (29) . This involvement would lead to transcriptional activation of inhibitor of apoptosis protein (IAP-1; ref. 43) , together with sustained extracellular signal-related kinase (ERK) activity (44) and suppression of p53 and the cyclin-dependent kinase inhibitor p21 WAF1/CIP1 (45) . Similar to our studies with cultured SMCs, blocking endothelial cell α v β 3 integrin interactions with either cyclic peptides or functional blocking antibodies induces apoptosis leading to vessel loss (46, 47) . Moreover, an α v β 3 integrin survival signal within the vasculature has been further supported by α v knockout mice, which exhibit an embryonically lethal phenotype (48) . Whereas evidence for an α v β 3 -TN SMC survival pathway is strong, as provided by this report and others (18) , these studies appear, at first, to be inconsistent with the presence of only a mild phenotype when TN is knocked out (49) . Reconciliation of these facts is likely to involve the presence of redundant cell survival signals, as our present data suggests, such as coordinate upregulation of OPN, an alternative α v β 3 integrin ligand.
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The OPN is expressed by SMCs present in vascular disease (34) , and its role as a survival factor has been reported in endothelial cells (29) . We have now shown that exogenous OPN can also support survival of SMCs when proteinase inhibition suppresses ECM survival ligands. Indeed, failure to expand a proliferative, TN-negative subpopulation following proteinase inhibition correlated with loss of both TN and OPN. The possibility exists that OPN expression by SMCs is enhanced by proteinase activity enabling them to respond to pro-proliferative cues. Although we have not identified other characteristics that differentiate the TN-dependent SMCs that apoptose following TN antisense treatment from the TN-independent cells that produce increased OPN, these results are in keeping with recent work by Frid and colleagues (50) documenting heterogeneity of PA SMCs. Such heterogeneous populations suggest the potential for an adaptive response to alterations in cell matrix interactions in disease.
In our study regression of hypertrophy involved both a loss of cellular and matrix components, whereas previous studies have addressed only a requirement for a reduction in cellularity (51) . Loss of ECM, paradoxically in the presence of proteinase inhibitors, may have resulted from phagocytosis and intracellular degradation by vascular cells (52) . Matrix degradation within vesicular membranes would have been inaccessible to the inhibitors used in our study. Alternatively, proteolysis of ECM may have been the effect of enzymes not targeted by the inhibitors used in our study, e.g., by release of upregulated apoptosis-associated enzymes with ECMdegrading capacities into the microenvironment (53) .
These organ culture studies have suggested a novel strategy to induce regression of vascular disease. Proteinase inhibitors produce a robust apoptotic response accompanied by loss of ECM, whereas the heterogeneity and plasticity of vascular SMC subpopulations appear to limit the usefulness of targeting specific ECM survival factors.
